Fingerprint
Dive into the research topics of 'A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma
Thomas E. Witzig, John K. Camoriano, Georgene Schroeder, Paul J. Kurtin, Thomas M. Habermann
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations